First monoclonal antibody therapy for prevention of migraine

View source ↗

Summary

EMA announces the approval of the first monoclonal antibody therapy for prevention of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• erenumab (erenumab)